DNLI
Denali Therapeutics Inc
Price:  
21.66 
USD
Volume:  
2,176,013.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DNLI Stock Forecast & Price Target

DNLI Stock Price Forecast

The average stock forecast for Denali Therapeutics Inc (DNLI) in the next 12 months is 34.61 USD. This price target corresponds to an upside of 64.66%. The range of stock forecasts for DNLI is 20.20 - 44.10 USD. Based on the ratings of 25 analysts, the consensus recommendation for DNLI is BUY.
Target Low Average Median High
Price (USD) 20.20 34.61 35.70 44.10
Upside -3.90% 64.66% 69.84% 109.80%

Recommendation Trends

The latest consensus rating for DNLI is "BUY". This is the average recommendation of 25 analysts: 0 strong sell, 0 sell, 2 hold, 12 buy, 11 strong buy. In the previous period, 25 analysts also majorly recommmended "BUY" for DNLI.

DNLI Financial Stock Forecast

Revenue This Year
23.51M
from -M
Revenue Next Year
140.30M
496.84%
from 23.51M
EPS This Year
-2.59
-19.74%
from -3.23
EPS Next Year
-2.41
-7.10%
from -2.59